These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6824563)

  • 81. Effects of a single dose of mianserin on sleep.
    Morgan K; Oswald I; Borrow S; Adam K
    Br J Clin Pharmacol; 1980 Nov; 10(5):525-7. PubMed ID: 7437266
    [No Abstract]   [Full Text] [Related]  

  • 82. Reduction of the hypotensive effect of clonidine and alpha-methyldopa by various psychotropic drugs.
    Zwieten PA
    Clin Sci Mol Med Suppl; 1976 Dec; 3():411s-413s. PubMed ID: 1071657
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Unusual appetites in patients on mianserin.
    Harris B; Harper M
    Lancet; 1980 Mar; 1(8168 Pt 1):590. PubMed ID: 6102302
    [No Abstract]   [Full Text] [Related]  

  • 84. Effect of mianserin on cardiac conduction.
    Burrows GD; Davies B; Hamer A; Vohra J
    Med J Aust; 1979 Jul; 2(2):97-8. PubMed ID: 492044
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine).
    Frith CD; Dowdy J; Ferrier IN; Crow TJ
    Psychopharmacology (Berl); 1985; 87(4):490-3. PubMed ID: 3936108
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The pharmacokinetics of mianserin.
    Shami M; Elliott HL; Kelman AW; Whiting B
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):313S-322S. PubMed ID: 6824562
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Influence of age on mianserin pharmacokinetics.
    Altamura AC; Melorio T; Invernizzi G; Gomeni R
    Psychopharmacology (Berl); 1982; 78(4):380-2. PubMed ID: 6818603
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.
    Reid JL
    Br J Clin Pharmacol; 1981 Sep; 12(3):295-302. PubMed ID: 7295459
    [No Abstract]   [Full Text] [Related]  

  • 89. A pharmacokinetic study of mianserin.
    Maguire KP; Norman TR; Burrows GD; Scoggins BA
    Eur J Clin Pharmacol; 1982; 21(6):517-20. PubMed ID: 7075657
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels.
    Clemmesen L; Mikkelsen PL; Lund H; Bolwig TG; Rafaelsen OJ
    Psychopharmacology (Berl); 1984; 82(4):348-54. PubMed ID: 6427827
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of methyldopa on psychometric performance.
    Johnson B; Hoch K; Errichetti A; Johnson J
    J Clin Pharmacol; 1990 Dec; 30(12):1102-5. PubMed ID: 2273082
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Chemical design of peripherally acting compounds.
    Jackson WR; Copp FC; Cullen JD; Guyett FJ; Rae ID; Robinson AJ; Pothoulackis H; Serelis AK; Wong M
    Clin Exp Pharmacol Physiol; 1992 Jan; 19(1):17-23. PubMed ID: 1623633
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of methantheline bromide and clonidine hydrochloride on salivary secretion.
    Wilson EL; Whitsett LD; Whitsett TL
    J Prosthet Dent; 1984 Nov; 52(5):663-5. PubMed ID: 6149315
    [No Abstract]   [Full Text] [Related]  

  • 94. The pharmacological profile of lofepramine, a new antidepressant drug.
    Sjögren C
    Neuropharmacology; 1980 Dec; 19(12):1213-4. PubMed ID: 7442952
    [No Abstract]   [Full Text] [Related]  

  • 95. Neurogenic Hypertension, the Blood-Brain Barrier, and the Potential Role of Targeted Nanotherapeutics.
    Lamptey RNL; Sun C; Layek B; Singh J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768536
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antidepressant Drugs Effects on Blood Pressure.
    Calvi A; Fischetti I; Verzicco I; Belvederi Murri M; Zanetidou S; Volpi R; Coghi P; Tedeschi S; Amore M; Cabassi A
    Front Cardiovasc Med; 2021; 8():704281. PubMed ID: 34414219
    [TBL] [Abstract][Full Text] [Related]  

  • 97. "First-dose" response to mianserin: effects of age.
    Swift CG; Swift MR; Tiplady B
    Psychopharmacology (Berl); 1988; 96(2):273-6. PubMed ID: 3148155
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.
    Elliott HL; Whiting B; Reid JL
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):323S-328S. PubMed ID: 6824563
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.
    Elliott HL; McLean K; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1983; 24(1):15-9. PubMed ID: 6299752
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.